DURECT Corp (NASDAQ:DRRX)
| 0.6382 Delayed Data As of 3:58pm ET |  +0.0395 / +6.60%Today’s Change | 0.36 Today|||52-Week Range 1.44 | -35.27% Year-to-Date |
Latest DRRX News | Press Releases
| Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content | United Therapeutics (UTHR) Q2 Earnings Lag Estimates Aug 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.60 |
| Today’s open | 0.58 |
| Day’s range | 0.58 - 0.64 |
| Volume | 5,236 |
| Average volume (3 months) | 1,095,790 |
| Market cap | $137.8M |
Data as of 3:58pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | -139.38% |
| Earnings growth (this year) | +8.33% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -53.58% |
| P/E ratio | NM |
| Price/Sales | 15.87 |
| Price/Book | 2.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATNMActinium Pharmaceuti... | -0.26 | -4.54% |
| SLGLSol Gel Technologies... | +0.26 | +4.49% |
| ---- | ||
| VRCAVerrica Pharmaceutic... | +0.06 | +1.78% |
Data as of 4:00pm ET, 08/08/2022
Financials
| Next reporting date | November 7, 2022 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $14.0M |
| Annual profit (last year) | -$36.3M |
| Net profit margin | -259.46% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cupertino, California |
Forecasts
